Iridian Asset Management’s Genprex GNPX Stock Holding History

Iridian Asset Management’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1	Closed	-$247K	–	122
2021 Q1	$247K	Buy	+1	New	+$220K	﹤0.01%	109

Other funds holding GNPX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Iridian Asset Management's GNPX Position: Q2 2021 in Review

Iridian Asset Management sold out of Genprex (GNPX) in Q2 2021, closing a stake of 1 share — an estimated $247K sold.

Iridian Asset Management first reported a position in GNPX in Q1 2021 and held it in 1 quarter. The position peaked at $247K in Q1 2021. 32 funds tracked by Wall St. Rank hold GNPX as of Q2 2021.

Iridian Asset Management reported no remaining Genprex position as of Q2 2021 after selling out during the quarter.
Iridian Asset Management sold 1 Genprex share in Q2 2021, an estimated $247K.
Iridian Asset Management first reported a position in Genprex in Q1 2021 and held it in 1 quarter.
Iridian Asset Management's Genprex position peaked at $247K in Q1 2021.
32 funds tracked by Wall St. Rank held Genprex as of Q2 2021.

Based on Iridian Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.